AAAAAA

   
Results: 1-11 |
Results: 11
EVALUATING THE EFFECT OF TREATMENTS ON FUNCTIONAL HEALTH AND WELL-BEING - AN ANALYSIS OF 100 AND 78 SF-36 STUDIES (1988-1997)
Authors: MANOCCHIA M WARE JE
Citation: M. Manocchia et Je. Ware, EVALUATING THE EFFECT OF TREATMENTS ON FUNCTIONAL HEALTH AND WELL-BEING - AN ANALYSIS OF 100 AND 78 SF-36 STUDIES (1988-1997), Medical decision making, 18(4), 1998, pp. 478-478
THE US ORPHAN DRUG PROGRAM - 1983-1995
Authors: SHULMAN SR MANOCCHIA M
Citation: Sr. Shulman et M. Manocchia, THE US ORPHAN DRUG PROGRAM - 1983-1995, PharmacoEconomics, 12(3), 1997, pp. 312-326
ISSUES IN PHARMACEUTICAL LOTTERIES - THE CASE OF INTERFERON BETA-1B
Authors: MANOCCHIA M LASAGNA L
Citation: M. Manocchia et L. Lasagna, ISSUES IN PHARMACEUTICAL LOTTERIES - THE CASE OF INTERFERON BETA-1B, Clinical pharmacology and therapeutics, 62(3), 1997, pp. 241-247
INITIATIVES TO SPEED NEW DRUG DEVELOPMENT AND REGULATORY REVIEW - THEIMPACT OF FDA-SPONSOR CONFERENCES
Authors: DIMASI JA MANOCCHIA M LASAGNA L
Citation: Ja. Dimasi et al., INITIATIVES TO SPEED NEW DRUG DEVELOPMENT AND REGULATORY REVIEW - THEIMPACT OF FDA-SPONSOR CONFERENCES, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 13-13
US APPROVED BIOLOGICS - 1980-1994
Authors: GOSSE ME MANOCCHIA M KAITIN KI
Citation: Me. Gosse et al., US APPROVED BIOLOGICS - 1980-1994, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 15-15
THE NEW DRUG APPROVALS OF 1993, 1994, AND 1995 - TRENDS IN DRUG DEVELOPMENT
Authors: KAITIN KI MANOCCHIA M LASAGNA L
Citation: Ki. Kaitin et al., THE NEW DRUG APPROVALS OF 1993, 1994, AND 1995 - TRENDS IN DRUG DEVELOPMENT, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 16-16
DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE
Authors: BAKKE OM MANOCCHIA M DEABAJO F KAITIN KI LASAGNA L
Citation: Om. Bakke et al., DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE, Clinical pharmacology and therapeutics, 58(1), 1995, pp. 108-117
DRUG SAFETY DISCONTINUATIONS - A COMPARISON OF UK, US, AND SPAIN 1974-93
Authors: BAKKE OM MANOCCHIA M DEABAJO F KAITIN KI LASAGNA L
Citation: Om. Bakke et al., DRUG SAFETY DISCONTINUATIONS - A COMPARISON OF UK, US, AND SPAIN 1974-93, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 195-195
THE DRUG EXPORT AMENDMENTS ACT OF 1986 - IS IT ALL IT WAS INTENDED TOBE
Authors: SHULMAN SR MANOCCHIA M SEIBRING M
Citation: Sr. Shulman et al., THE DRUG EXPORT AMENDMENTS ACT OF 1986 - IS IT ALL IT WAS INTENDED TOBE, Food and drug law journal, 49(2), 1994, pp. 367-384
THE DRUG EXPORT AMENDMENTS ACT OF 1986 - IS IT ALL IT WAS INTENDED TOBE
Authors: SHULMAN SR MANOCCHIA M SEIBRING M
Citation: Sr. Shulman et al., THE DRUG EXPORT AMENDMENTS ACT OF 1986 - IS IT ALL IT WAS INTENDED TOBE, Food and drug law journal, 49(2), 1994, pp. 367-384
THE NEW DRUG APPROVALS OF 1990, 1991, AND 1992 - TRENDS IN DRUG DEVELOPMENT
Authors: KAITIN KI MANOCCHIA M SEIBRING M LASAGNA L
Citation: Ki. Kaitin et al., THE NEW DRUG APPROVALS OF 1990, 1991, AND 1992 - TRENDS IN DRUG DEVELOPMENT, Journal of clinical pharmacology, 34(2), 1994, pp. 120-127
Risultati: 1-11 |